ED
APH icon

Exane Derivatives’s Amphenol APH Stock Holding History

Exane Derivatives’s Portfolio APH Stock Details APH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,540
Closed -$25.9K – 576
2016
Q4 		$25.9K Hold
1,540
– – 0.01% 351
2016
Q3 		$25K Hold
1,540
– – ﹤0.01% 343
2016
Q2 		$22.1K Buy
1,540
+740
+93% +$10.6K ﹤0.01% 324
2016
Q1 		$11.6K Buy
+800
New +$10.4K ﹤0.01% 405

Other funds holding APH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Exane Derivatives's APH Position: Q1 2017 in Review

Exane Derivatives sold out of Amphenol (APH) in Q1 2017, closing a stake of 1,540 shares — an estimated $25.9K sold.

Exane Derivatives first reported a position in APH in Q1 2016 and held it in 4 quarters. The position peaked at $25.9K in Q4 2016. 546 funds tracked by Wall St. Rank hold APH as of Q1 2017.

  • Exane Derivatives reported no remaining Amphenol position as of Q1 2017 after selling out during the quarter.
  • Exane Derivatives sold 1,540 Amphenol shares in Q1 2017, an estimated $25.9K.
  • Exane Derivatives first reported a position in Amphenol in Q1 2016 and held it in 4 quarters.
  • Exane Derivatives's Amphenol position peaked at $25.9K in Q4 2016.
  • 546 funds tracked by Wall St. Rank held Amphenol as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.